Interact to see
Advertisement
Advertisement
ACWZX vs NRGSX
ACWZX vs NRGSX Comparison
Open Charts ACWZX vs NRGSX
AMG GW&K Small/Mid Cap Growth Z
Price$19.76
Change+$0.34 (+1.75%)
VolumeN/A
Net Assets38.01M
Neuberger Berman Genesis R6
Price$63.54
Change+$0.45 (+0.71%)
VolumeN/A
Net Assets8.79B
ACWZX vs NRGSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.8B vs. ACWZX (38M). NRGSX pays higher dividends than ACWZX: NRGSX (0.06) vs ACWZX (0.00). ACWZX was incepted earlier than NRGSX: ACWZX (4 years) vs NRGSX (13 years). ACWZX (1.05) is less costly to investors than NRGSX (0.74). ACWZX is a more actively managed with annual turnover of: 19.00 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than ACWZX: NRGSX (0) vs ACWZX (5000000). ACWZX annual gain was more profitable for investors over the last year : 8.67 vs. NRGSX (-7.18).
| ACWZX | NRGSX | ACWZX / NRGSX | |
| Total Expense Ratio | 0.82 | 0.74 | 111% |
| Annual Report Gross Expense Ratio | 1.05 | 0.74 | 142% |
| Fund Existence | 4 years | 13 years | - |
| Gain YTD | 7.471 | -3.458 | -216% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 38M | 8.8B | 0% |
| Annual Yield % from dividends | 0.00 | 0.06 | - |
| Returns for 1 year | 8.67 | -7.18 | -121% |
| Returns for 3 years | 46.79 | 9.33 | 502% |
| Returns for 5 years | N/A | -1.44 | - |
| Returns for 10 years | N/A | 10.14 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AFMBX | 39.09 | 0.17 | +0.44% |
| American Funds American Balanced F3 | |||
| CECYX | 30.38 | N/A | N/A |
| Columbia Large Cap Enhanced Core Inst3 | |||
| GMCUX | 16.99 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Equity R6 | |||
| PRIAX | 35.03 | N/A | N/A |
| Principal Glb Emerging Markets A | |||
| CVMAX | 22.22 | N/A | N/A |
| Calvert Emerging Markets Equity A | |||